[Inhibitory effect of transforming growth factor-β(1) on oral squamous cell carcinoma brain metastasis Tb cell line]

Zhonghua Kou Qiang Yi Xue Za Zhi. 2010 Jul;45(7):421-5.
[Article in Chinese]

Abstract

Objective: To investigate the inhibitory effect of transforming growth factor (TGF)-β₁ on oral squamous cell carcinoma (OSCC) Tb cell line.

Methods: Cell counting method was used to examine the inhibitory effect of TGF-β₁ on Tb cell and flow cytometry (FCM) assay performed to measure the changes of cell cycle. Superarray was used to screen the changing expression of genes in TGF-β₁/Smads signaling pathway.RT-PCR method was used to detect the results of Superarray.

Results: TGF-β₁ showed significant inhibiting effect on OSCC Tb cell line. TGF-β₁ blocked the cell cycle at G₁ phase. The expression level of activin receptor-like kinase-1 (ACVRL-1), anti-mullerian hirmine (AMH), cyclim-dependent kinase inhibitor-2B (CDKN-2B) and transforming growth factor-beta-indnced factor (TGIF) was higer in the cells treated with TGF-β₁ than in control, while TDGF-1 expression was down-regulated. ACVRL-1 and CDKN-2B gene expression was consistent with the results of Superarray.

Conclusions: TGF-β₁ can inhibit the growth of OSCC Tb cell line. The mechanism may be related to the regulation of cell cycle and the expression of ACVRL-1 and CDKN-2B in TGF-β₁-Smads signaling pathway.

Publication types

  • English Abstract

MeSH terms

  • Activin Receptors, Type II / metabolism
  • Anti-Mullerian Hormone / metabolism
  • Carcinoma, Squamous Cell / pathology*
  • Cell Cycle Checkpoints
  • Cell Line, Tumor
  • Cyclin-Dependent Kinase Inhibitor p15 / metabolism
  • Humans
  • Neoplasm Metastasis
  • Signal Transduction
  • Transforming Growth Factor beta1 / pharmacology*

Substances

  • CDKN2B protein, human
  • Cyclin-Dependent Kinase Inhibitor p15
  • Transforming Growth Factor beta1
  • Anti-Mullerian Hormone
  • ACVRL1 protein, human
  • Activin Receptors, Type II